8-K 1 a4750520.txt DIAGNOSTIC PRODUCTS 8-K U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 --------------------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 26, 2004 ---------------- Diagnostic Products Corporation ------------------------------- (Exact name of Registrant as specified in its charter) California 1-9957 95-2802182 ---------- ------ ---------- (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 5210 Pacific Concourse Drive, Los Angeles, California 90045-6900 ---------------------------------------------------- (Address of principal executive offices) (Zip Code) (310) 645-8200 ---------------------------------------------------- (Registrant's telephone number, including area code) 5700 West 96th Street, Los Angeles, California 90045 ------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Diagnostic Products Corporation Current Report on Form 8-K ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On October 26,2004, Diagnostic Products Corporation announced its results of operations for the quarter ended September 30, 2004. A copy of the related press release is being furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference in its entirety. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits. No. 99.1 Press Release issued by Diagnostic Products Corporation, dated October 26, 2004. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 26, 2004 Diagnostic Products Corporation By: /s/ James L. Brill ------------------------------- James L. Brill, Vice President, Finance EXHIBIT INDEX Exhibit Number -------------- 99.1 Press Release issued by Diagnostic Products Corporation, dated October 26, 2004.